Comparative analysis with collagen type II distinguishes cartilage oligomeric matrix protein as a primary TGFβ-responsive gene

This publication has 37 references indexed in Scilit:

• Cartilage oligomeric matrix protein expression in systemic sclerosis reveals heterogeneity of dermal fibroblast responses to transforming growth factor β
  Annals of the Rheumatic Diseases, 2009
• Repression of chondrogenesis through binding of notch signaling proteins HES‐1 and HEY‐1 to N‐box domains in the COL2A1 enhancer site
  Arthritis & Rheumatism, 2008
• Skeletal Abnormalities in Mice Lacking Extracellular Matrix Proteins, Thrombospondin-1, Thrombospondin-3, Thrombospondin-5, and Type IX Collagen
  The American Journal of Pathology, 2008
• Leukemia/Lymphoma-related Factor, a POZ Domain-containing Transcriptional Repressor, Interacts with Histone Deacetylase-1 and Inhibits Cartilage Oligomeric Matrix Protein Gene Expression and Chondrogenesis
  Journal of Biological Chemistry, 2004
• SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  Molecular Pharmacology, 2002
• Chondrogenic Differentiation of Mesenchymal Stem Cells from Bone Marrow: Differentiation-Dependent Gene Expression of Matrix Components
  Experimental Cell Research, 2001
• Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies
  Tissue Engineering, 2001
• Thrombospondin-1 Is a Major Activator of TGF-β1 In Vivo
  Cell, 1998
• Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene
  Nature Genetics, 1995
• Mutations in exon 17B of cartilage oligomeric matrix protein (COMP) cause pseudoachondroplasia
  Nature Genetics, 1995